“The long game here is not to make money selling kits, although the kits are essential to get the base level data,” says board member Patrick Chung. “Once you have the data, [23andMe] does actually become the Google of personalized health care.”
卡塞的诉讼就是针对这一行为，她的律师称之为：“伪装拙劣的把戏，诱导人们花钱[给23andMe]建立DNA数据库。”23andMe公司也承认生物银行是公司的核心战略。“长期大局不是卖小服务赚钱，尽管这一小服务确实是获取基层数据的关键，”董事帕特里克·钟（Patrick Chung）说，“只要有数据，[23andMe]便成了实际上的个性化医疗领域的谷歌。”